generations of glp 1 agonists Oral Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies A schematic overview of GLP-1

Ochs D, Wolf DP

elegans VANG-1 Modulates Life Span via Insulin/IGF-1-Like Signaling"

The upregulation of the tumour suppressor gene P53 leads to the accumulation of lipid hydroperoxides by inhibiting the expression of SLC7A11 and reducing the level of GSH, eventually triggering ferroptosis [81]

doi: 10.3389/fcell.2024.1405546 185

Subsequently, roGFP2-iL was fused behind human GRX1 to generate GRX1-roGFP2-iL (Figure 1C) to ensure specificity of the novel probe for E GSH similar to other roGFP variants used before (Gutscher et al., E

The impact of renal or hepatic impairment on peptide clearance has not been characterized for either compound